Literature DB >> 25633435

Comparison of plasma levels of nutrient-related biomarkers among Japanese populations in Tokyo, Japan, São Paulo, Brazil, and Hawaii, USA.

Motoki Iwasaki1, Adrian A Franke, Gerson S Hamada, Nelson T Miyajima, Sangita Sharma, Junko Ishihara, Ribeka Takachi, Shoichiro Tsugane, Loïc Le Marchand.   

Abstract

Previous studies of Japanese migrants have suggested that the increase in colorectal cancer rates occurring after migration is slower among Japanese Brazilians than among Japanese Americans. We hypothesized that this difference may partly reflect differences in vegetable and fruit intake between the populations. Using data from validation studies of food frequency questionnaires being used in comparative case-control studies of colorectal adenoma in Tokyo, São Paulo, and Hawaii, plasma carotenoid, retinol, tocopherol, and coenzyme Q10 levels were measured by high-performance liquid chromatography, and 25-hydroxy vitamin D levels were estimated by enzyme-linked immunosorbent assay. Plasma levels were compared by analysis of covariance between 142 Japanese in Tokyo, 79 Japanese Brazilians in São Paulo, and 78 Japanese Americans in Hawaii. Overall, we found significantly lower plasma carotenoid levels, except for lycopene levels, and retinol levels in Japanese Americans compared with Japanese in Tokyo and Japanese Brazilians. The plasma total carotenoid level was highest in Japanese Brazilians. Compared with the mean level among Japanese Brazilians (1741.2 ng/ml), P for difference was 0.03 among Japanese in Tokyo (1514.4 ng/ml) and less than 0.01 for Japanese Americans (1257.7 ng/ml). Plasma lycopene and tocopherol levels did not substantially differ between the three populations. We also found significantly lower plasma levels of 25-hydroxy vitamin D and total coenzyme Q10 in Japanese in Tokyo than in Japanese Americans and Japanese Brazilians. Higher levels of plasma carotenoids among Japanese Brazilians than among Japanese in Tokyo and Hawaii may have contributed to the slower pace of the increase in colorectal cancer rates observed in that population after migration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25633435      PMCID: PMC4313381          DOI: 10.1097/CEJ.0000000000000136

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  29 in total

1.  Changes in plasma antioxidant status following consumption of diets high or low in fruit and vegetables or following dietary supplementation with an antioxidant mixture.

Authors:  I R Record; I E Dreosti; J K McInerney
Journal:  Br J Nutr       Date:  2001-04       Impact factor: 3.718

2.  Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative.

Authors:  G C Kabat; M Y Kim; G E Sarto; J M Shikany; T E Rohan
Journal:  Eur J Clin Nutr       Date:  2011-12-14       Impact factor: 4.016

3.  Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population.

Authors:  Simona Ognjanovic; Jennifer Yamamoto; Barbara Saltzman; Adrian Franke; Miodrag Ognjanovic; Lance Yokochi; Thomas Vogt; Robert Decker; Loïc Le Marchand
Journal:  Cancer Causes Control       Date:  2010-03-24       Impact factor: 2.506

4.  Validation of a quantitative FFQ for a study of diet and risk of colorectal adenoma among Japanese Brazilians.

Authors:  Mohammadreza Pakseresht; Nelson Tomio Miyajima; Andrew Shelton; Motoki Iwasaki; Shoichiro Tsugane; Loic Le Marchand; Sangita Sharma
Journal:  Public Health Nutr       Date:  2012-08-14       Impact factor: 4.022

5.  Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.

Authors:  Sara Gandini; Mathieu Boniol; Jari Haukka; Graham Byrnes; Brian Cox; Mary Jane Sneyd; Patrick Mullie; Philippe Autier
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

6.  Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies.

Authors:  Jung Eun Lee; Haojie Li; Andrew T Chan; Bruce W Hollis; I-Min Lee; Meir J Stampfer; Kana Wu; Edward Giovannucci; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-23

7.  Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study.

Authors:  Weiwen Chai; Robert V Cooney; Adrian A Franke; Christian P Caberto; Lynne R Wilkens; Loïc Le Marchand; Marc T Goodman; Brian E Henderson; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-04       Impact factor: 4.254

8.  Interaction between adiponectin and leptin influences the risk of colorectal adenoma.

Authors:  Taiki Yamaji; Motoki Iwasaki; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

9.  Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study.

Authors:  Weiwen Chai; Robert V Cooney; Adrian A Franke; Yurii B Shvetsov; Christian P Caberto; Lynne R Wilkens; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-28       Impact factor: 4.254

10.  Validity of a self-administered food frequency questionnaire for middle-aged urban cancer screenees: comparison with 4-day weighed dietary records.

Authors:  Ribeka Takachi; Junko Ishihara; Motoki Iwasaki; Satoko Hosoi; Yuri Ishii; Shizuka Sasazuki; Norie Sawada; Taiki Yamaji; Taichi Shimazu; Manami Inoue; Shoichiro Tsugane
Journal:  J Epidemiol       Date:  2011-10-01       Impact factor: 3.211

View more
  2 in total

1.  Prospective study of plasma levels of coenzyme Q10 and lung cancer risk in a low-income population in the Southeastern United States.

Authors:  Chris Shidal; Hyung-Suk Yoon; Wei Zheng; Jie Wu; Adrian A Franke; William J Blot; Xiao-Ou Shu; Qiuyin Cai
Journal:  Cancer Med       Date:  2021-02-06       Impact factor: 4.452

2.  Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.

Authors:  Toshihiro Yoneyama; Sumio Ohtsuki; Kazufumi Honda; Makoto Kobayashi; Motoki Iwasaki; Yasuo Uchida; Takuji Okusaka; Shoji Nakamori; Masashi Shimahara; Takaaki Ueno; Akihiko Tsuchida; Naohiro Sata; Tatsuya Ioka; Yohichi Yasunami; Tomoo Kosuge; Takashi Kaneda; Takao Kato; Kazuhiro Yagihara; Shigeyuki Fujita; Wilber Huang; Tesshi Yamada; Masanori Tachikawa; Tetsuya Terasaki
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.